A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...
The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and ...
1don MSN
Immune sabotage: How a vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...
A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...
The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback